tr~~ilo/~lrugoidc~.~ furinuc have been shown to be important factors in the development of bronchial asthma and allergic rhinitis. Group I and group I1 antigens with apparent molecular masses of 24 kD. (Drr p I and DcrJ'I) and 15 k D (Der p I1 and Drr,f 11). respectively. have been purified (1. 2). Most mite-allergic patients have measurable amounts of IgE antibodies to these allergens (3) .
The cDNA clone encoding D o 17 I1 has been isolated by IgE plaque RIA (4) . The deduced amino acid sequences revealed that it consisted of 129 amino acid residues containing six cysteine residues. IgE from 90% of mite-allergic patients reacted with Der p 11 (5) (6) (7) (8) . Recent studies from this (9) and other laboratories ( 10, 1 1 ) have also revealed that IgG from patients with bronchial asthma strongly recognized Drr p I1 and Dc~r,/'lI. We measured the antibodies of IgG subclasses to the purified Dcr p 11 (9) . The levels of antibodies to total IgG and in all IgG subclasses in asthmatic patients were higher than those of nonatopic healthy individuals.
Epitope mapping of Dc~r p I1 for IgE binding has recently been studied using peptides expressed from D r r p 11 cDNA constructs (12) or synthetic peptides (13) . However, there have been no reports of epitope analysis of D r r p I1 using the native protein.
The antibody binding capacity is extremely resistant to denaturing conditions such as heat treatment or low and high pH. In the present study. we digested the purified Dorp I1 with cyanogen bromide and proteases and examined both IgG and IgE binding to the peptides obtained.
MATERIALS A N D M E T H O D S
Scv-u. Sera from 10 children with bronchial asthma (aged 1-15 y old) who had never received immunotherapy were collected and pooled for the immunoblotting analysis of the mite antigen. All of these patients exhibited positive results to IgE radioallergosorbent tests (score >3+) (Pharmacia LKB Biotechnology. Uppsala, Sweden). The severity of the condition of these patients was mild to moderate. Most patients were medicated with theophyllin. disodium cromglycate. and 82-inhalator.
Pur~ficution of' Der p II. D. ptcronjssinrrc was cultivated by the method of Miyamoto c' t ul. (15). After cultivation, culture media and mite bodies were collected by repipetting flotation on saturated NaCl solution as described by Sasa ct ul. ( 1 6). Collected mite bodies were then homogenized with a Polytron homogenizer, and the homogenate was centrifuged at 100 000 x s for 20 min. The supernatant obtained, i .~. , crude mite extract. was then dialyzed against 10 mM Tris buffer (pH 7.4) for 2 d. The crude mite extract was applied to a Sephadex G 75 column and eluted with 10 mM Tris buffer (pH 7.4). Each fraction was then analyzed by SDS-PAGE by the method of Luctnrnli (17) . The fractions containing proteins with an apparent molecular mass of 15 k D were collected and applied to a reverse-phase HPLC using a Cx column (Cosmosil, Nakarai Industrial Co. Ltd., Tokyo. Japan) equilibrated with 0.1 % (vol/vol) trifluoroacetic acid. Bound materials were eluted with a linear gradient of 20 to 80% out with an amino acid sequencer (470A: Applied Biosystems. Inc.. Foster City. CA) and on-line I20A HPLC. lysylendopeptidase. V8 protease. and TPCK-treated trypsin were electrophoresed on a 15% polyacrylamide gel. The peptides were then electrically transferred to a Millipore PVDF membrane in 10 mM CAPS buffer (3-[cyclohexylamino]-I-propanesulfonic acid, pH 1 1 .O) containing 10% methanol. The PVDF membrane was rinsed with deionized water for 5 min and stained with Ponseau-S (Sigma). The peptide stained on the PVDF membrane was cut and applied to the amino acid sequencer described above (20, 2 1 ).
Imrnrrnohlot~ing unal1:~i.r. Dcr p 11 treated with CNBr or proteases was subjected to SDS-PAGE and electrotransferred to a nitrocellulose sheet by the method of Towbin rl 01. (22) . The nitrocellulose sheet was incubated with 5% (wt/vol) skim milk containing 0.2% (vol/vol) Triton X-100 in 10 m M PBS. pH 7.4 (buffer A), at room temperature for 30 min to block nonspecific binding. The sheet was then incubated with the pooled sera (l:50 dilution) from patients with bronchial asthma in buffer A at 4°C overnight and washed with 0.2% (wt/vol) Triton X-100 in PBS for 60 min with three changes. Next. the sheet was incubated with horseradish peroxidase-conjugated goat anti-human IgG (Tago Inc.. Burlingame, CA) or horseradish peroxidase-conjugated anti-human IgE (Tago Inc.) at 37°C for 90 min. After washing with 0.2% (vol/vol) Triton X-100 in PBS, the sheet was substrated with diaminobenzidine tetrachloride (Katayama Chemical Co. Ltd., Tokyo. Japan).
RESULTS

Dc~r11
I1 was digested with lysylendopeptidase and analyzed by SDS-PAGE. The enzyme treatment produced two major peptides ( Fig. 1.-1) , Lys-l and Lys-2. with apparent molecular masses of 6.5 kD and 4 kD, respectively. both of whose amino terminal sequence began at the 56th residue (Ah5') of the Dcrp 11. Because of the enzyme specificity and the molecular size on the electrophoretic gel. it is likely that the peptide Lys-l is the carboxyl terminal half of the protein from the 56th residue. The same amount of peptides was analyzed by immunoblotting with the pooled patient sera (Fig. IB) . IgG and IgE from patient's sera clearly recognized control Drrp 11. whereas they bound to neither Lys-l nor Lys-2. When skin tests were performed on 10 patients with bronchial asthma using Lys-l and Lys-2 isolated by HPLC, these peptides induced positive skin reaction in none of the patients examined. 
The effects of reduction and/or S-pyridylethylation of D c r p I1 on IgG and IgE binding were examined. D c~r p I1 was electrophoresed under nonreducing or reducing condition or after S-pyridylethylation. Nonreduced and reduced proteins showed the same intensity on both the IgG and the IgE bindings. S-pyridylethylated protein also showed positive staining with Ig, though its binding was weak (data not shown). These results indicate that reduction of disulfide bonds in the Dcr p I1 molecule does not affect the binding of IgG and IgE, but that the formation of S-pyridylethylated cysteine reduced the IgG and IgE binding. However, these data also suggest that S-pyridylethylated protein may be used for further analysis of enzyme-treated protein. because the native form of Der p I1 is resistant to the attack of trypsin and V8 protease. but S-pyridylethylated proteins become susceptible to these proteases.
Next, S-pyridylethylated Dcrp I1 wasdigested with V8 protease and the peptides were analyzed by immunoblotting. Both IgG and IgE bound to the major peptide produced (Fig. 3, V 8 -I ) in addition to the undigested protein. V8-1 was identified as the carboxyl terminal region from the 13th residue (Ile"). V8-2, which was from the 39th residue (Ala3')), exhibited negative staining with IgG and IgE. These data suggest that the 13th to the 39th residues may be responsible for binding IgG and IgE.
Treatment of S-pyridylethylated protein with TPCK-treated trypsin produced the peptide Tr-I. which was the carboxyl terminal side from the 15th residue (Lys"). lmmunoblotting analysis revealed that both IgG and IgE bound to Tr-l (Fig. 4) . indicating that the binding site for IgG and IgE exists in the carboxyl terminal region from the 15th residue. The result corresponds to that obtained from the treatment of Dcr p I1 with V8 protease.
DISCUSSION
In the present study, immunoblotting analysis was used to study the binding of IgG and IgE from children with bronchial asthma to the peptides that were produced by the treatments of native Dcr p 11 with CNBr and proteases. Schematic figures of Dcr p I1 peptides and summary of the IgG and IgE binding studies are shown in Figure 5 . Ig bound to the peptide from the amino terminus to the 76th residue and to the carboxyl terminal side from the 13th or the 15th residue. However. IgG and IgE failed to bind to the carboxyl terminal side from the 39th. 56th, o r 77th residue. The present study indicates that the amino terminal half of Dc.r p I1 is more important for the binding of IgG and IgE than the carboxyl terminal half and suggests that the 15th to 39th residues may be directly related to the binding of lg.
We have determined the amino terminal sequences of the peptides obtained and deduced the residues that make them up using the specificities of CNBr and proteases and molecular masses on electrophoretic gel. Thus, there is a possibility that the peptide lost its ability to bind with Ig due to the cleavage of the carboxyl terminus with the enzymes. In the present study. it was clearly demonstrated that the peptide lacking the residues 1 to 15 (Tyr-I) could bind with Ig. whereas the one lacking the residues I to 39 (V8-2) showed no such activity. We have not determined whether human IgG and IgE bind directly to the peptide comprising residues 15 to 39. but it is possible to conclude that these residues are required for the binding of IgG and IgE to Dcr p 11. Dcr p I1 has been shown to be heat stable and resistant to treatments at pH 2.0 or pH 12.0 and to denaturation with 6 M guanidine in terms of binding by murine MAb and human IgE to this protein (14) . However, after reduction and alkylation. antibody binding was reduced (14) . Our result from the study of binding by human IgG and IgE to reduced and S-pyridylethylated Dcr p I1 corresponds to their result. Native Dc~r 17 I1 is protease resistant, but we found that reduced and S-pyridylethylated Dc,r p I1 became susceptible to the attack of proteases such as VX protease and trypsin, although the modified protein itself decreased binding by IgG and IgE. The only protease that was able to digest the native Dc~r p I1 among various enzymes we have tested was lysylendopeptidase. Isolated peptides digested with lysylendopeptidase failed to induce positive skin reaction in patients with bronchial asthma: this result is consistent with that obtained by immunoblotting analysis with human IgE. When reductive methylated I k r p I1 with sodium cyanoborohydride and formaldehyde (23) p I1 peptides a n d s u m m a r y o f t h e IgG a n d IgE binding studies. Peptides were obtained from the treatments o f D e r p I1 with lysylendopeptidase (1,~:s-I a n d -2). C N B r (C'NBr-u, -h, a n d -1.). S. ulrrc,rt.s V8 protease ( W -I a n d -2) a n d TPCK-treated trypsin ( T r y -/ ) as described under Materials a n d Methods a n d Results. T h e a m i n o acid residues a r e based o n t h e a m i n o terminal sequences. the specificities o f C N B r a n d proteases. a n d molecular masses o n electrophoretic gel.
Sepharose 4B and used as solid-phase antigens to the binding with human IgE. Although 90% of the sera from mite-allergic patients reacted with Dsr p 11. only 60% of the sera tested in their study bound to Sepharose-coupled peptides 65 to 78. We studied the epitope mapping of Dc. r p I1 with IgE, using the purified Drr p 11. Our results suggest that residues 15 to 39 may be important: this is different from the result obtained by Van't Hof et 01. ( 1 3) . This discrepancy may be due to the differences of antigens and assays used; we used native protein and immunoblotting assay. IgE binding to residues 65 to 78 was low in their study: only very few patients had appreciable amounts of IgE-anti-mite directed against peptides 65 to 78.
Tsai ( . I ul. (24) reported that the titer of mite-specific IgG4 in the asthmatics, which was determined by ELISA using crude mite extract. was 2.23 times higher than that in the control group. Chapman and Platts-Mills (25) also measured antibodies to partially purified mite antigens containing Der p I and 11. IgG antibody to the mite antigens was detected in sera from 94% of mite-allergic patients and from 30% of nonallergic controls. In our recent study (9) , the levels of antibodies of total IgG and of all IgG subclasses to the purified Der p I1 in patients with bronchial asthma, who had never received immunotherapy, were higher than those of nonatopic healthy individuals. 
